Compound ID | 1314
Class: Fluoroquinolone
Spectrum of activity: | Gram-positive |
Details of activity: | For treatment of conventional and biothreat infections. |
Institute where first reported: | Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, and bClinical Laboratory, Zhangshu People’s Hospital, Zhangshu, PR China |
Year first mentioned: | 2012 |
Highest developmental phase: | Phase 1 |
Development status: | Active |
Chemical structure(s): | |
Canonical SMILES: | C1CC2CN(CC2NC1)C3=C(C4=C(C=C3F)C(=O)C(=CN4C5CC5)C(=O)O)OC(F)F |
Isomeric SMILES: | C1CC2CN(CC2NC1)C3=C(C=C4C(=C3OC(F)F)N(C=C(C4=O)C(=O)O)C5CC5)F |
InChI: | InChI=1S/C21H22F3N3O4/c22-14-6-12-16(27(11-3-4-11)8-13(18(12)28)20(29)30)19(31-21(23)24)17(14)26-7-10-2-1-5-25-15(10)9-26/h6,8,10-11,15,21,25H,1-5,7,9H2,(H,29,30) |
InChI Key: | KNLARSZRTBDTIA-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/75253538 |
External links: | |
Guide to Pharmacology: | chinfloxacin |
Main Source: | https://aac.asm.org/content/62/12/e01087-18 |
Citation: | https://www.karger.com/Article/Abstract/337084 |